Internationally recognized leaders in inflammatory bowel disease bring deep expertise spanning ulcerative colitis, Crohn’s ...

(WSPA)—Inflammatory bowel disease (IBD) targets your digestive system. As part of our “Ask the Expert” series, in partnership ...

Jan 29 (Reuters) - Agomab Therapeutics is targeting a valuation of up to $828.5 million in its initial public offering (IPO) ...

Inflammatory Bowel Disease (IBD) is a chronic disease of inflammation along the digestive tract. There are two forms of IBD, ...

Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million in its Nasdaq debut, joining a series of ...

Outcomes in new cohort are favorable and consistent to previously reported randomized cohort for Crohn's Perianal Fistulas -NEWARK, Del., Jan. 29, 2026 ...

Agomab Therapeutics (AGMB), a Belgian biotech focused on immunology and inflammatory diseases files for a U.S. IPO to raise ...

The Dallas native - who played for Oklahoma State and Utah State - was last year sentenced to 26 months behind bars after being arrested for illegally importing a batch of edibles from Thailand.

President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices ...

Other symptoms that can accompany children's stomachaches include sore throat, heartburn, fever, bloating and painful ...

AgomAb Therapeutics NV ( AGMB) has filed to raise $200 million in development capital in an IPO of its American Depositary Shares representing underlying common shares, according to SEC F-1/A ...